rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Benjamin F. McGraw III

Director

Company insider

Files Form 4 as: Director, Evommune; Interim Executive Chair, Aerie Pharmaceuticals; Director, Ista Pharmaceuticals; COB, President and CEO, Valentis.

Every Form 4 they filed

In numbers

Trades disclosed
57
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
4
Companies where not an officer
2
First trade
20 Oct 2004
Last trade
2 Jun 2026
Last filed
3 Jun 2026

Companies traded

Where they are an officer
Aerie PharmaceuticalsDirector, Officer · last 21 Nov 20220 buys · 0 sells
ValentisDirector, Officer · last 30 Jun 20070 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
EVMN EvommuneDirector · Biotechnology · last 2 Jun 20260 buys · 0 sells
Ista PharmaceuticalsDirector · last 6 Jun 20120 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
2 Jun 2026filed 3 Jun 2026EVMN Evommuneoption or derivative · BiotechnologySEC FORM 4 Code A—15,673 at $0.00filing
2 Jun 2026filed 3 Jun 2026EVMN Evommuneoption or derivative · BiotechnologySEC FORM 4 Code A—15,673 at $0.00filing
5 Nov 2025filed 7 Nov 2025EVMN Evommuneoption or derivative · BiotechnologySEC FORM 4 Code A—37,960 at $0.00filing
21 Nov 2022filed 21 Nov 2022Aerie Pharmaceuticalsoption or derivativeSEC FORM 4 Code D$15K7,800 at $1.98filing
21 Nov 2022filed 21 Nov 2022Aerie Pharmaceuticalsoption or derivativeSEC FORM 4 Code D$375K102,412 at $3.66filing
21 Nov 2022filed 21 Nov 2022Aerie Pharmaceuticalsoption or derivativeSEC FORM 4 Code D$154K16,854 at $9.14filing
21 Nov 2022filed 21 Nov 2022Aerie PharmaceuticalsSEC FORM 4 Code D$640K41,984 at $15.25filing
9 Jun 2022filed 13 Jun 2022Aerie Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—16,854 at $0.00filing
9 Jun 2022filed 13 Jun 2022Aerie PharmaceuticalsSEC FORM 4 Code A—6,245 at $0.00filing
28 Feb 2022filed 2 Mar 2022Aerie PharmaceuticalsSEC FORM 4 Code F$86K10,324 at $8.30filing
20 Sep 2021filed 22 Sep 2021Aerie Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—102,412 at $0.00filing
20 Sep 2021filed 22 Sep 2021Aerie PharmaceuticalsSEC FORM 4 Code A—34,513 at $0.00filing
17 Jun 2021filed 21 Jun 2021Aerie PharmaceuticalsSEC FORM 4 Code A—1,750 at $0.00filing
17 Jun 2021filed 21 Jun 2021Aerie Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—7,800 at $0.00filing
11 Jun 2020filed 29 Jun 2020Aerie Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—7,800 at $0.00filing
11 Jun 2020filed 29 Jun 2020Aerie PharmaceuticalsSEC FORM 4 Code A—1,750 at $0.00filing
23 May 2019filed 23 May 2019Aerie Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—7,800 at $0.00filing
23 May 2019filed 23 May 2019Aerie PharmaceuticalsSEC FORM 4 Code A—1,750 at $0.00filing
7 Jun 2018filed 8 Jun 2018Aerie Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—7,800 at $0.00filing
7 Jun 2018filed 8 Jun 2018Aerie PharmaceuticalsSEC FORM 4 Code A—1,750 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.